En español
NIDA

Menu

Agenda

116th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

February 4, 2014

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

12:30 p.m. Call to Order
Nora Volkow, M.D., Director, NIDA

Review of and Policy Procedures
Mark Swieter, Ph.D., Acting Executive Secretary,
National Advisory Council on Drug Abuse, NIDA
12:45 p.m. Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Phil Skolnick, Ph.D., D.Sc. (hon.), Director
Division of Basic Neuroscience and Behavioral Research (DBNBR)
Joni Rutter, Ph.D., Acting Director
Division of Clinical Neuroscience and Behavioral Research (DCNBR)
Joseph Frascella, Ph.D., Director
Division of Epidemiology, Services, and Prevention Research (DESPR)
Redonna Chandler, Ph.D., Acting Director
Office of Science Policy and Communications (OSPC)
Jack Stein, Ph.D., Director
  2:00 - 2:15 p.m. Break - End of closed session

Open Session

2:15 p.m. Opening and Welcome New Members
Nora Volkow, M.D. Director, NIDA
2:45 p.m. Director's Report
Nora Volkow, M.D. Director, NIDA
3:45 p.m. Council Discussion
Council Members
4:15 p.m. Council Operating Procedures and Delegation of Authority
Mark Swieter, Ph.D.
Acting Director, Office of Extramural Affairs,
NIDA and Executive Secretary,
NACDA
4:20 p.m.

Concept Clearances
Geetha Subramaniam, M.D.
Deputy Director,
Center for Clinical Trials Network,
NIDA

Steven Sparenborg, Ph.D.
Addiction Medicine Team Leader,
Center for Clinical Trials Network,

NIDA

Joni Rutter, Ph.D., Director
Division of Basic Neuroscience and
Behavioral Research (DBNBR), NIDA

Lisa Onken, Ph.D., Chief
Behavioral Treatment and Development Branch,
Division of Clinical Neuroscience and
Behavioral Research, NIDA

4:50 p.m. Public Comments
5:00 p.m. Adjourn

Second Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism
National Advisory Council on Drug Abuse, and National Cancer Advisory Board

NIH Main Campus, Bldg. One, Wilson Hall
Rockville Pike
Bethesda MD 20892

February 5, 2014

Closed Session 8:30-9:00 a.m. Review of Cran Applications

8:30-9:00 a.m. Call to Order
Dr. Nora Volkow
Dr. Ken Warren
8:35 a.m. Conflict and Confidentiality
Dr. Mark Swieter
Dr. Abe Bautista
8:40 a.m. Revision Applications En Bloc Concurrence
Dr. Susan Weiss
8:45 a.m. Administrative Supplements
9:00 a.m. Adjournment of the Closed Session

Open to the Public 9:15 a.m. to 12:30 p.m.

(Videocast Joint Session Only)

9:15 a.m. Call to Order and Introductions
Dr. George Koob
Dr. Nora Volkow
9:30 a.m. NIDA Director's Report
Dr. Nora Volkow
9:45 a.m. NIAAA Director's Report
Dr. George Koob
10:00 a.m. NIH Director's Remark
Dr. Francis Collins
10:15 a.m. Break
10:30 a.m. Update on Marijuana Administrative Supplements
Dr. Marsha Lopez
10:45 a.m. Collaborative Training Considerations
Dr. John Krystal
11:15 a.m. FY 2015 Cran Concept Clearance
Training Opportunities
Adolescent Treatment Concept
Dr. Lorraine Gunzerath
Dr. Geetha Subramanian
Dr. Will Aklin
12:00 p.m. Discussion
NIAAA, NIDA and NCI Council Members
12:30 p.m. Adjournment

 

This page was last updated January 2014

    Featured Publication

    Featured Publication

    Drugs, Brains, and Behavior - The Science of Addiction

    As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.